Anavex Life Sciences (AVXL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.31, -11.49% vs the prior close of $1.48.
- Volume 1.47M shares, 1.5x its 50-day average.
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
AVXL slides 11.5% to $1.31, a 52-week low. Closed at $1.31, -11.49% vs the prior close of $1.48. Day range $1.30–$1.47, opened at $1.47.
AVXL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AVXL slides 11.5% to $1.31, a 52-week low
- Closed at $1.31, -11.49% vs the prior close of $1.48. Day range $1.30–$1.47, opened at $1.47.
- Volume was 1.47M shares, 1.5x its 50-day average of 976.84K.
- Price is -48.5% vs its 50-day average ($2.54) and -59.5% vs its 200-day average ($3.23).
- 52-week range $1.30–$9.50; today's close sits at 0% of that range, 86.2% below the 52-week high.
Oct 15, 2026 — AVXL dips 0.7% to $1.48 on 1.8x normal volume
- Closed at $1.48, -0.67% vs the prior close of $1.49. Day range $1.47–$1.54, opened at $1.50.
- Volume was 1.75M shares, 1.8x its 50-day average of 964.80K — unusually heavy trading.
- Price is -42.7% vs its 50-day average ($2.58) and -54.4% vs its 200-day average ($3.25).
- 52-week range $1.44–$9.50; today's close sits at 0% of that range, 84.4% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — AVXL rises 0.7% to $1.49
- Closed at $1.49, +0.68% vs the prior close of $1.48. Day range $1.45–$1.55, opened at $1.45.
- Volume was 1.23M shares, 1.3x its 50-day average of 979.83K.
- Price is -43.1% vs its 50-day average ($2.62) and -54.3% vs its 200-day average ($3.26).
- 52-week range $1.44–$9.50; today's close sits at 1% of that range, 84.3% below the 52-week high.
Oct 13, 2026 — AVXL dips 2.0% to $1.48, a 52-week low
- Closed at $1.48, -1.99% vs the prior close of $1.51. Day range $1.48–$1.53, opened at $1.53.
- Volume was 1.19M shares, 1.2x its 50-day average of 984.82K.
- Price is -44.2% vs its 50-day average ($2.65) and -54.7% vs its 200-day average ($3.27).
- 52-week range $1.44–$9.50; today's close sits at 0% of that range, 84.4% below the 52-week high.
Oct 12, 2026 — AVXL rises 1.3% to $1.51
- Closed at $1.51, +1.34% vs the prior close of $1.49. Day range $1.45–$1.54, opened at $1.47.
- Volume was 1.19M shares, 1.2x its 50-day average of 984.93K.
- Price is -43.7% vs its 50-day average ($2.68) and -54.0% vs its 200-day average ($3.28).
- 52-week range $1.44–$9.52; today's close sits at 1% of that range, 84.1% below the 52-week high.
Oct 9, 2026 — AVXL slides 3.2% to $1.49, a 52-week low
- Closed at $1.49, -3.25% vs the prior close of $1.54. Day range $1.44–$1.54, opened at $1.54.
- Volume was 1.29M shares, 1.3x its 50-day average of 984.17K.
- Price is -44.9% vs its 50-day average ($2.70) and -54.7% vs its 200-day average ($3.29).
- 52-week range $1.44–$9.95; today's close sits at 1% of that range, 85.0% below the 52-week high.
Oct 8, 2026 — AVXL rises 0.7% to $1.54
- Closed at $1.54, +0.65% vs the prior close of $1.53. Day range $1.50–$1.58, opened at $1.53.
- Volume was 1.47M shares, 1.5x its 50-day average of 976.81K.
- Price is -43.6% vs its 50-day average ($2.73) and -53.4% vs its 200-day average ($3.30).
- 52-week range $1.50–$10.10; today's close sits at 0% of that range, 84.8% below the 52-week high.
Oct 7, 2026 — AVXL slides 4.4% to $1.53, a 52-week low, 6 down days in a row
- Closed at $1.53, -4.38% vs the prior close of $1.60. Day range $1.51–$1.61, opened at $1.57.
- Volume was 1.33M shares, 1.4x its 50-day average of 965.64K.
- Price is -44.3% vs its 50-day average ($2.75) and -53.8% vs its 200-day average ($3.31).
- 52-week range $1.51–$10.38; today's close sits at 0% of that range, 85.3% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 — AVXL dips 2.7% to $1.60, a 52-week low, 5 down days in a row
- Closed at $1.60, -2.74% vs the prior close of $1.64. Day range $1.56–$1.71, opened at $1.66.
- Volume was 1.43M shares, 1.5x its 50-day average of 951.28K.
- Price is -42.2% vs its 50-day average ($2.77) and -51.9% vs its 200-day average ($3.33).
- 52-week range $1.56–$10.38; today's close sits at 0% of that range, 84.6% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — AVXL slides 9.6% to $1.64, a 52-week low on 2.2x normal volume
- Closed at $1.64, -9.62% vs the prior close of $1.82. Day range $1.63–$1.82, opened at $1.79.
- Volume was 2.02M shares, 2.2x its 50-day average of 931.05K — unusually heavy trading.
- Price is -41.0% vs its 50-day average ($2.79) and -50.7% vs its 200-day average ($3.34).
- 52-week range $1.63–$10.38; today's close sits at 0% of that range, 84.2% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — AVXL slides 3.7% to $1.82, a 52-week low on 2.2x normal volume
- Closed at $1.82, -3.70% vs the prior close of $1.89. Day range $1.72–$1.88, opened at $1.88.
- Volume was 1.99M shares, 2.2x its 50-day average of 914.87K — unusually heavy trading.
- Price is -35.0% vs its 50-day average ($2.80) and -45.6% vs its 200-day average ($3.35).
- 52-week range $1.72–$10.38; today's close sits at 1% of that range, 82.5% below the 52-week high.
- That makes 3 straight losses.
AVXL latest news & SEC filings
Every SEC filing by or about AVXL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 5, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 5, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.01 — Change in control of the company.
- Item 5.07 — Reported shareholder vote results.
Sep 21, 2026 · Form DFAN14A — DFAN14A filing
DFAN14A filing
Sep 18, 2026 · Form DFAN14A — DFAN14A filing
DFAN14A filing
Sep 17, 2026 · Form DFAN14A — DFAN14A filing
DFAN14A filing
Sep 15, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 15, 2026 · Form DFAN14A — DFAN14A filing
DFAN14A filing
Sep 14, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 10, 2026 · Form DFAN14A — DFAN14A filing
DFAN14A filing
Sep 10, 2026 · Form DFAN14A — DFAN14A filing
DFAN14A filing
Sep 9, 2026 · Form DFAN14A — DFAN14A filing
DFAN14A filing
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade AVXL
- Last results release: Aug 25, 2026 (8-K Item 2.02). Previous ones: Jul 30, 2026, Feb 9, 2026, Nov 25, 2025. Based on that rhythm, the next report is likely around Nov 24, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.69% (largest 14.4%). That is a volatile stock.
- Liquidity: about 1.38M shares (≈$1.81M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.31 vs a range of $1.30–$9.50 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 15, 2026; 8-K Sep 28, 2026; 8-K Sep 9, 2026.
- Share count: 92.70M shares outstanding (Aug 28, 2026), +7.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
AVXL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.47 | 1.47 | 1.30 | 1.31 | 1.47M |
| Oct 15, 2026 | 1.50 | 1.54 | 1.47 | 1.48 | 1.77M |
| Oct 14, 2026 | 1.45 | 1.55 | 1.45 | 1.49 | 1.23M |
| Oct 13, 2026 | 1.53 | 1.53 | 1.48 | 1.48 | 1.19M |
| Oct 12, 2026 | 1.47 | 1.54 | 1.45 | 1.51 | 1.19M |
| Oct 9, 2026 | 1.54 | 1.54 | 1.44 | 1.49 | 1.29M |
| Oct 8, 2026 | 1.53 | 1.58 | 1.50 | 1.54 | 1.47M |
| Oct 7, 2026 | 1.57 | 1.61 | 1.51 | 1.53 | 1.33M |
| Oct 6, 2026 | 1.66 | 1.71 | 1.56 | 1.60 | 1.43M |
| Oct 5, 2026 | 1.79 | 1.82 | 1.63 | 1.64 | 2.02M |
| Oct 2, 2026 | 1.88 | 1.88 | 1.72 | 1.82 | 1.99M |
| Oct 1, 2026 | 2.00 | 2.01 | 1.88 | 1.89 | 2.34M |
| Sep 30, 2026 | 2.38 | 2.38 | 1.89 | 2.02 | 2.96M |
| Sep 29, 2026 | 2.35 | 2.41 | 2.31 | 2.36 | 1.76M |
| Sep 28, 2026 | 2.42 | 2.43 | 2.35 | 2.35 | 522.50K |
| Sep 25, 2026 | 2.35 | 2.43 | 2.32 | 2.38 | 744.40K |
| Sep 24, 2026 | 2.33 | 2.37 | 2.27 | 2.34 | 937.10K |
| Sep 23, 2026 | 2.47 | 2.49 | 2.31 | 2.35 | 778.90K |
| Sep 22, 2026 | 2.41 | 2.48 | 2.39 | 2.47 | 639.90K |
| Sep 21, 2026 | 2.42 | 2.42 | 2.35 | 2.40 | 574.50K |
About Anavex Life Sciences
Anavex Life Sciences (AVXL) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in NEW YORK, NY. Fiscal year ends September 30. SEC CIK 1314052.
AVXL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Christopher U Missling | President and CEO | Jan 9, 2026 |
| Axel Paeger | Director | May 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sandra Boenisch | PFO & Treasurer | Sep 28, 2026 |
| Terrie Kellmeyer | Interim CEO | May 14, 2026 |
| Christopher U Missling | President and CEO | Jan 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
AVXL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | — | $-46.38M | -0.54 | $-39.04M |
| Sep 30, 2024 | — | $-43.00M | -0.52 | $-30.81M |
| Sep 30, 2023 | — | $-47.51M | -0.60 | $-27.79M |
| Sep 30, 2022 | — | $-47.98M | -0.62 | $-24.24M |
| Sep 30, 2021 | — | $-37.91M | -0.54 | $-30.38M |
Latest balance sheet: total assets $120.14M, total liabilities $7.69M, cash $118.33M (as of Jun 30, 2026).
AVXL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 25, 2026 | 8-K Item 2.02 (results) | $3.56 |
| Jul 30, 2026 | 8-K Item 2.02 (results) | $2.70 |
| Feb 9, 2026 | 8-K Item 2.02 (results) | $4.35 |
| Nov 25, 2025 | 8-K Item 2.02 (results) | $3.46 |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Dec 28, 2020 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AVXL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.